Search

everythinglearnresearchcommunity

for

Search:↓

A male with aromatase deficiency improved bone health with estradiol treatment.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

Higher fluoride levels may delay puberty in boys.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

High BMI worsens hair growth in women with PCOS.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Testosterone's muscle-building effects do not require its conversion to DHT.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Testosterone improves mood and thinking skills; finasteride has no effect.